Gemfibrozil
Gemfibrozil is a pharmaceutical drug with 30 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 27 completed trials
Phase Distribution
Phase Distribution
23
Early Stage
4
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
96.4%
27 of 28 finished
3.6%
1 ended early
0
trials recruiting
30
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.
Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects
A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081
Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant
A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects
Clinical Trials (30)
Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.
Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects
A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081
Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant
A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects
A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy Adults
A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants
A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants
A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy Subjects
A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A
The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream
Gemfibrozil for Nicotine Smoking Cessation
A Study of Evacetrapib in Healthy Participants
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)
Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction
Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927
Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 30